Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
US12156863B2 · kind B2 · utility
0Cited by
43References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2021 |
| Grant date | Dec 3, 2024 |
| Priority date | — |
| Expiry date | Feb 17, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating cancer in a subject includes administering an active agent selected from ascorbic acid, an ascorbic acid derivative, and/or a pharmaceutically acceptable salt thereof and administering a pentaaza macrocyclic ring complex corresponding to formula (I) below:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.